|
Washington Report: New Partnerships Pursue Old Diseases (Pharmaceutical Executive)
A new wave of collaborations between industry, non-profits, and government seeks affordable treatments for neglected diseases around the world.
(Sep 8, 2006)
Partners HealthCare And Affymetrix Collaborate To Develop Microarray Diagnostics (BioresearchOnline)
Affymetrix Inc. and Partners HealthCare announced that they have entered into a three-year translational research collaboration to develop microarray-based diagnostics for complex diseases such as newborn hearing loss, autism and hypertrophic cardiomyopathy
(Sep 8, 2006)
Power3 Identifies Early-Detection Biomarkers For Parkinson's Disease (BioresearchOnline)
Power3 Medical Products, Inc., said it has discovered 11 biomarkers which have demonstrated the ability to identify Parkinson's disease in its early stages through serum-based testing, as well as differentiate between Parkinson's and Parkinson's-like diseases
(Sep 8, 2006)
Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the (PR Newswire via Yahoo! Finance)
Eli Lilly and Company chairman and chief executive officer, Sidney Taurel, today outlined the promises of the coming biomedical revolution in a speech at the Economic Club of Florida, comparing scientists today to Ponce de Leon landing on the shores of Florida with an entire continent to explore.
(Sep 8, 2006)
Genome Code Cracked For Breast And Colon Cancers (Science Daily)
Johns Hopkins Kimmel Cancer Center scientists have completed the first draft of the genetic code for breast and colon cancers. Their report, published online in the September 7 issue of Science, identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control.
(Sep 8, 2006)
Syngenta Seeds Inc. converting its fleet to renewable fuels from customers’ products (SeedQuest)
More than ever, corn and soybeans are fueling the fleet of Syngenta ’s corn and soybean business. The company has converted 34 percent of the light-duty vehicles in its fleet to run on E-85 fuel and 43 percent of its heavy-duty vehicles to biodiesel.
(Sep 8, 2006)
Consortium for Functional Glycomics awarded $40.7 million 'glue' grant (EurekAlert!)
The Consortium for Functional Glycomics was formed in response to the NIGMS announcement that it would provide glue grants to support multi-disciplinary, multi-institutional research projects that would be considered beyond the means of any one group.
(Sep 8, 2006)
UC Davis receives $1.5M for Tourette's syndrome research (BizJournals)
Ron and Darin Mittelstaedt of El Dorado Hills have pledged up to $1.5 million to create a new Tourette's syndrome research and treatment program at the UC Davis Medical Investigation of Neurodevelopmental Disorders Institute.
(Sep 8, 2006)
UC Davis receives $1.5M for Tourette's syndrome research (bizjournals.com via Yahoo! Finance)
Ron and Darin Mittelstaedt of El Dorado Hills have pledged up to $1.5 million to create a new Tourette's syndrome research and treatment program at the University of California Davis research center for developmental diseases of the brain.
(Sep 8, 2006)
Microarray Platforms Largely Consistent, FDA Study Concludes (Bio-IT World)
September 08, 2006 | DNA microarrays from the leading commercial sources are more reliably consistent than previously suspected, according to a new study coordinated by the U.S. Food and Drug Administration (FDA).
(Sep 8, 2006)
Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the (RedNova)
TALLAHASSEE, Fla., Sept. 8 /PRNewswire-FirstCa
(Sep 8, 2006)
Federal MicroArray Quality Control Study Addresses Intercompatability of Microarray Gene Expression Platforms (Business Wire via Yahoo! Finance)
SAN DIEGO----Sept. 8, 2006--The FDA-led MicroArray Quality Control project findings announced today show that microarray gene expression data from the commercial platforms tested in the study show high degrees of correlation.
(Sep 8, 2006)
Clinical Data, Inc. Plays Integral Role in MicroArray Quality Control (MAQC) Consortium Project (Business Wire via Yahoo! Finance)
NEWTON, Mass.----Sept. 8, 2006--Cogenics, a division of Clinical Data Inc. and comprised of the combined companies of Genaissance Pharmaceuticals, Lark , Icoria, and Genome Express of France, today joined with other participants of the MicroArray Quality Control Consortium in publishing the results of the FDA-led initiative to assess the precision, reproducibility and comparability of microarray
(Sep 8, 2006)
Affymetrix Participates in Study to Advance MicroArray Technology Towards Widespread Clinical Use (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif.----Sept. 8, 2006--Affymetrix Inc. announced today the publication of the MicroArray Quality Control study, a collaborative effort led by the FDA that included 137 scientists from private and public sector laboratories.
(Sep 8, 2006)
CORRECTING and REPLACING Federal MicroArray Quality Control Study Addresses Intercompatability of Microarray Gene (Business Wire via Yahoo! Finance)
SAN DIEGO----Sept. 8, 2006--First graph, correct url should read: http://www.nature.com/nbt/focus/maqc/index.html .
(Sep 8, 2006)
EU, US And Canada To Collaborate To Increase Understanding Of The Genetic Make-up Of Human Diseases (Medical News Today)
The European Commission, US National Institutes of Health and Genome Canada are today announcing a global collaborative research programme designed to lead to better understanding of human diseases. [click link for full article]
(Sep 9, 2006)
In A Technical Tour De Force, Scientists Take A Global View Of The Epigenome (Science Daily)
A collaboration between researchers at the Salk Institute for Biological Studies and the University of California at Los Angeles captured the genome-wide DNA methylation pattern of the plant Arabidopsis thaliana - the "laboratory rat" of the plant world - in one big sweep. "In a single experiment we recapitulated 20 years worth of anecdotal findings and then some," says senior author Joseph
(Sep 9, 2006)
Unusual Three-drug Combo Inhibits Growth Of Aggressive Tumors (Science Daily)
An experimental anti-cancer regimen combined a diuretic, a Parkinson's disease medication and a drug ordinarily used to reverse the effect of sedatives. The unusual mixture inhibited the growth of aggressive prostate tumors in laboratory mice in research conducted at Washington University School of Medicine in St. Louis.
(Sep 9, 2006)
Genome Code Cracked For Breast And Colon Cancers (Medical News Today)
Johns Hopkins Kimmel Cancer Center scientists have completed the first draft of the genetic code for breast and colon cancers. Their report, published online in the September 7 issue of Science Express, identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control. [click link for
(Sep 9, 2006)
Women moving up to top university jobs (The Arizona Republic)
Across the Valley, women are moving into the highest positions in schools of business and engineering, and they're bringing innovative new approaches to their jobs.
(Sep 10, 2006)
Briefs: Free prostate exams offered (The Herald-Sun)
CHAPEL HILL -- UNC Health Care urologists will offer free prostate examinations to members of the public from 1 to 7 p.m. Sept. 27 and 28. Appointments are not required, but those interested are encouraged to make an appointment by calling 966-1316.
(Sep 10, 2006)
Grants geared to making U.S. safer (The News & Observer)
Since Sept. 11, Triangle researchers have found that money goes to projects with security applications.
(Sep 10, 2006)
New EMBL Partnership Will Advance The Understanding Of Complex Biological Systems (Medical News Today)
Today the European Molecular Biology Laboratory (EMBL), the Centre for Genomic Regulation (CRG) and the Spanish Ministry for Education and Science (MEC) officially launch their new joint EMBL/CRG Research Unit in Systems Biology on the campus of the Barcelona Biomedical Research Park. The Spanish Ministry for Education and Science will fund the new unit with 12. [click link for full article]
(Sep 10, 2006)
Study backs microarray data / Report concerning automated gene-scanning instruments helps to validate entire class of (San Francisco Chronicle)
Forget the old VHS versus Betamax wars at the dawn of the videotape machine era, or the incompatible brains of Mac computers and PCs. Biotechnology has been grappling with an even thornier format quandary concerning one of its key tools, and the issue...
(Sep 10, 2006)
Unusual Three-drug Combo Inhibits Growth Of Aggressive Tumors (Medical News Today)
An experimental anti-cancer regimen combined a diuretic, a Parkinson's disease medication and a drug ordinarily used to reverse the effect of sedatives. The unusual mixture inhibited the growth of aggressive prostate tumors in laboratory mice in research conducted at Washington University School of Medicine in St. Louis. [click link for full article]
(Sep 10, 2006)
DoD Awards $10.7 Million Center Of Excellence Grant To Fox Chase's V. Craig Jordan (Medical News Today)
V. Craig Jordan, OBE, Ph.D., D.Sc., of Fox Chase Cancer Center has received a $10.7 million grant from the Department of Defense Breast Cancer Research Program for a Breast Cancer Center of Excellence focused on developing a new treatment model for breast cancer to reverse the eventual development of resistance to anti-estrogen therapy. [click link for full article]
(Sep 10, 2006)
Get Shorty: Pathway Toward Gene Silencing Described In Plants (Science Daily)
Biologists at Washington University in St. Louis have made an important breakthrough in understanding a pathway plant cells take to silence unwanted or extra genes using short bits of RNA. Basically, they have made it possible to see where, and how, the events in the pathway unfold within the cell, and seeing is believing, as the old saying goes.
(Sep 10, 2006)
Mayo Researchers Discover HIV Dependence On A Human Protein (Science Daily)
Mayo Clinic virologists have discovered that a specific human protein is essential for HIV to integrate into the human genome.
(Sep 10, 2006)
Van Andel Institute Brings World Renowned Scientists To Grand Rapids (Michigan Technology News)
GRAND RAPIDS - Van Andel Institute has brought some world renowned scientists to West Michigan to honor the lifetime achievements of VAI Research Director George Vande Woude and this year's Daniel Nathans Memorial Award co-recipients.
(Sep 11, 2006)
Asuragen Joins Industry Leaders in Completion of the FDA MAQC Project (Business Wire via Yahoo! Finance)
AUSTIN, Texas----Sept. 11, 2006--Asuragen, Inc., an oncology molecular diagnostic company and molecular biology service provider, announces its participation as an Affymetrix test site for the U.S.
(Sep 11, 2006)
ExonHit licenses Merck rights to RNA splicing microarray patent (News-Medical-Net)
ExonHit Therapeutics S.A., a drug and diagnostic discovery company, has announced that Merck & Co., Inc. has been granted a non-exclusive license to rights for research only under Patent US 6,881,571.
(Sep 11, 2006)
11 September 2006 (PharmiWeb)
Resources | Features | ICON expands experience in the deve... A new generation of oncology drugs is proving highly effective against certain cancers. For decades, chemotherapy, hormonal therapy and radiation were the preferred treatments for many cancers.
(Sep 11, 2006)
Hospital eyes downtown move (The Arizona Republic)
Executives of the state's only public hospital are spearheading efforts to replace the nearly 40-year-old Maricopa Medical Center with a new one closer to the medical hub in downtown Phoenix.
(Sep 11, 2006)
Shaking Out The Family Tree: Rice Domestiction Confirmed Genetically (Science Daily)
Biologists from Washington University in St. Louis and their collaborators from Taiwan have examined the DNA sequence family tree of rice varieties and have determined that the crop was domesticated independently at least twice in various Asian locales.
(Sep 11, 2006)
Maricopa Medical Center officials seeking new facility (KVOA Tucson)
PHOENIX The state's only public hospital could be replaced by a new facility closer to the medical hub in downtown Phoenix.
(Sep 11, 2006)
Jones Readies Search Engine (RedNova)
By Schnitzler, Peter For the last eight months, Indiana's resident high-tech guru has been quietly developing a new IT firm. Few details have been leaked to the public. But when the name Scott Jones is involved, nothing stays hush- hush for long.
(Sep 11, 2006)
Asuragen Joins Industry Leaders in Completion of the FDA MAQC Project (RedNova)
Asuragen, Inc., an oncology molecular diagnostic company and molecular biology service provider, announces its participation as an Affymetrix test site for the U.S.
(Sep 11, 2006)
MAQC Publishes Results of Large-Scale Comparative Microarray Study, Says Cross-Platform Data Are 'Reproducible and (GenomeWeb News)
If you have already registered, then login here . (To avoid this screen in the future, do not logout.)
(Sep 11, 2006)
Hospital eyes downtown move (The Arizona Republic)
Executives of the state's only public hospital are spearheading efforts to replace the nearly 40-year-old Maricopa Medical Center with a new one closer to the medical hub in downtown Phoenix.
(Sep 11, 2006)
Expression Analysis Announces its Participation in the First Phase of the MicroArray Quality Control (MAQC) Project (Business Wire via Yahoo! Finance)
DURHAM, N.C.----Sept. 11, 2006--Expression Analysis, Inc., a full-service microarray testing, analysis and data management organization, has announced its participation as an official data analysis site in the first phase of the Federal Drug Administration's MicroArray Quality Control Project.
(Sep 11, 2006)
Genetic Surprise: Mobile Genes Found To Pressure Species Formation (Science Daily)
Biologists at the University of Rochester have discovered that an old and relatively unpopular theory about how a single species can split in two turns out to be accurate after all, and acting in nature. The finding, reported in today's issue of Science, reveals that scientists must reassess the forces involved in the origin of species. The beginnings of speciation, suggests the paper, can be
(Sep 11, 2006)
Probe for glycoprotein developed (UPI)
TAIPEI, Taiwan, Sept. 11 (UPI) -- Scientists at Taiwan's Academia Sinica research center say they've developed a glycoprotein probe to better understand the process of cancer metastasis.
(Sep 11, 2006)
How molecular diagnostics has responded to industry trends (Medical Device Link)
An article published two years ago (IVD Technology, September 2004) discussed several trends in the healthcare industry as a whole, and their influence on the evolution and growth of molecular diagnostics. Those trends are still relevant today.
(Sep 11, 2006)
Mitsubishi Space Software Co. Ltd Enters into Distributorship Agreement with Waban Software, Inc. (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass. and TOKYO----Sept. 11, 2006--Mitsubishi Space Software Co. Ltd , a Systems & Information Technology firm that provides services, solutions and systems for government and enterprise in areas such as Space systems, Defense Systems, Bioinformatics, Security, Business Information Systems, Medical Systems etc., and, Waban Software, Inc. the leading provider of software products for
(Sep 11, 2006)
Unusual Three-drug Combo Inhibits Growth of Aggressive Tumors (Newswise)
An experimental anti-cancer regimen combined a diuretic, a Parkinson's disease medication and a drug ordinarily used to reverse the effect of sedatives. The unusual mixture inhibited the growth of aggressive prostate tumors in laboratory mice in research conducted at Washington University School of Medicine in St. Louis.
(Sep 11, 2006)
Natural Protective Mechanism Against Neuronal Death In Alzheimer's Found (Science Daily)
Researchers have uncovered what appears to be a natural protective mechanism against a central cause of neuronal death in Alzheimer's and similar neurodegenerative diseases. They theorize that it may be possible to use drugs to enhance that mechanism, to alleviate Alzheimer's pathology.
(Sep 11, 2006)
Inscent, Inc. Receives Federal Grant to Develop Platform Technologies With Agricultural, Biomedical, and Biosensor (PR Newswire via Yahoo! Finance)
Inscent, Inc. has received a Small Business Innovative Research grant from the US National Science Foundation to continue the development of novel technologies and products based on insect chemosensory proteins.
(Sep 11, 2006)
Sigma-Aldrich Launches New PhosphoProfile(TM) I Phosphopeptide Enrichment Kit (RedNova)
ST. LOUIS, Sept. 11 /PRNewswire-FirstCall/ -- Sigma-Aldrich Research Biotech, a division of Sigma-Aldrich , has launched the PhosphoProfile(TM) I Phosphopeptide Enrichment Kit, a new kit for the enrichment of phosphopeptides.
(Sep 12, 2006)
Inscent, Inc. Receives Federal Grant to Develop Platform Technologies With Agricultural, Biomedical, and Biosensor (SYS-CON Media)
Inscent, Inc. has received a Small Business Innovative Research grant from the US National Science Foundation to continue the development of novel technologies and products based on insect chemosensory proteins. The funded project concerns our proprietary high throughput assay system, Attenu. The Attenu system is a highly efficient assay for rapidly identifying molecules that bind to insect
(Sep 12, 2006)
Australia's jobs boom for robots (Sydney Morning Herald)
In the next 50 years, Australian robots will control mines, patrol the coastline and negotiate our harsh agricultural environment, preventing us from risk to our lives.
(Sep 12, 2006)
|
